beta-agonisté v gynekologii - doporučeno omezení

09.09.2013 10:06

EMA (Evropská léková agentura) oznámila následující:

Pharmacovigilance Risk Assessment Committee (PRAC) recommends restriction to the use of short-acting beta-agonists in obstetric indications

The PRAC recommended that medicines called ‘short-acting beta-agonists’ should no longer be used in oral or suppository forms in obstetric indications (for the care of pregnant women), such as for suppressing premature labour or excessive labour contractions. However, injectable forms of these medicines should remain authorised for short-term obstetric use under specific conditions.

Převzato a více informací na